Mylan Buys Aspen's European Thrombosis Business for $763 Million
Mylan Buys Aspen's European Thrombosis Business for $763 Million
GALWAY, IRELAND--August 31, 2020--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Mylan Ireland Limited (NASDAQ: MYL) has agreed to buy Aspen Pharmacare Holdings's European thrombosis business for 642 million euro ($763 million).
Within this article: Details purchase, price paid, products acquired, strategic directions of both companies, related deals
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
